Literature DB >> 31624060

Ranitidine: doctors should switch patients to alternative, says health department.

Elisabeth Mahase1.   

Abstract

Entities:  

Year:  2019        PMID： 31624060     DOI： 10.1136/bmj.l6087

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus-based guideline.

Authors:  D T Greenblatt; E Pillay; K Snelson; R Saad; M Torres Pradilla; S Widhiati; A Diem; C Knight; K Thompson; N Azzopardi; M Werkentoft; Z Moore; D Patton; K M Mayre-Chilton; D F Murrell; J E Mellerio
Journal:  Br J Dermatol       Date:  2021-11-25       Impact factor: 11.113

2.  Risk of Cancer in Association with Ranitidine and Nizatidine vs Other H2 Blockers: Analysis of the Japan Medical Data Center Claims Database 2005-2018.

Authors:  Masao Iwagami; Ryosuke Kumazawa; Yoshihisa Miyamoto; Yuri Ito; Miho Ishimaru; Kojiro Morita; Shota Hamada; Nanako Tamiya; Hideo Yasunaga
Journal:  Drug Saf       Date:  2020-11-27       Impact factor: 5.606

3.  Ranitidine: Is its injunction a warning bell?

Authors:  Saubhik Dasukil; Shiwangi Verma; Samapika Routray; Geetanjali Arora; Kiran Kumar Boyina
Journal:  Indian J Pharmacol       Date:  2021 Jan-Feb       Impact factor: 1.200
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.